Cargando…
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
Coronavirus disease 2019 (COVID‐19) is a highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). This deadly infection has resulted in more than 5.2 million deaths worldwide. The global rollout of COVID‐19 vaccines has without doubt saved countless liv...
Autores principales: | Forgham, Helen, Kakinen, Aleksandr, Qiao, Ruirui, Davis, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349879/ https://www.ncbi.nlm.nih.gov/pubmed/35941991 http://dx.doi.org/10.1002/EXP.20220012 |
Ejemplares similares
-
Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010) -
Rationally designed siRNAs without miRNA-like off-target repression
por: Seok, Heeyoung, et al.
Publicado: (2016) -
siRNA could be a potential therapy for COVID-19
por: Ghosh, Sanhita, et al.
Publicado: (2020) -
New perspective in heart failure management: could myosin activators be the answer?
por: Andrei, Stefan, et al.
Publicado: (2014) -
House dust mites use a plant-like siRNA pathway to silence transposable elements
por: Li, Lichao, et al.
Publicado: (2018)